Connor, Clark & Lunn Investment Management Ltd. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 203 filers reported holding SAGE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$4,388,330
-3.7%
93,329
-14.1%
0.02%
-12.0%
Q1 2023$4,557,779
+3.3%
108,622
-6.1%
0.02%0.0%
Q4 2022$4,411,463
+90.3%
115,665
+95.4%
0.02%
+66.7%
Q3 2022$2,318,000
+33.8%
59,183
+10.3%
0.02%
+36.4%
Q2 2022$1,733,000
+23.2%
53,643
+26.2%
0.01%
+57.1%
Q1 2022$1,407,000
-54.9%
42,503
-42.1%
0.01%
-53.3%
Q4 2021$3,121,000
+30.9%
73,377
+36.3%
0.02%
+25.0%
Q3 2021$2,385,000
+200.8%
53,833
+408.1%
0.01%
+200.0%
Q1 2021$793,000
+95.3%
10,596
+125.8%
0.00%
+100.0%
Q4 2020$406,0004,6920.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders